LEXICON PHARMACEUTICALS
Lexicon Pharmaceuticals, Inc. (formerly Lexicon Genetic) a biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of human disease, including immunology, metabolism, cardiology, and ophthalmology. The company's drug candidates include LX1031, which has completed Phase II clinical trials for the treatment of irritable bowel syndrome and other gastrointestinal disorders; LX4211 that has completed Phase II clinical trials to treat type 2 dia... betes; LX2931, which is in Phase II clinical trials for the treatment of rheumatoid arthritis and other autoimmune diseases; and LX1032 that has completed Phase II clinical trials to treat the symptoms associated with carcinoid syndrome. It also has a preclinical development drug candidate, LX7101, for the treatment of glaucoma. The company has drug discovery alliances with Bristol-Myers Squibb Company; Genentech, Inc.; N.V. Organon; and Takeda Pharmaceutical Company Limited. It also has drug development financing collaboration with Symphony Icon; collaboration agreement with Taconic Farms, Inc.; and an alliance with Nuevolution A/S, which provides access to Nuevolution's Chemetics platform chemistry technology.
LEXICON PHARMACEUTICALS
Industry:
Bioinformatics Biotechnology Medical Pharmaceutical
Founded:
1995-01-01
Address:
The Woodlands, Texas, United States
Country:
United States
Website Url:
http://www.lexpharma.com
Total Employee:
251+
Status:
Active
Contact:
281-863-3000
Email Addresses:
[email protected]
Total Funding:
448.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Universal Analytics Domain Not Resolving Apache Microsoft Exchange Online
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2001-06-13 | Coelacanth | Coelacanth acquired by Lexicon Pharmaceuticals | 32 M USD |
Investors List
Invus
Invus investment in Post-IPO Equity - Lexicon Pharmaceuticals
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Lexicon Pharmaceuticals
Invus
Invus investment in Post-IPO Equity - Lexicon Pharmaceuticals
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Lexicon Pharmaceuticals
USAMRMC
USAMRMC investment in Grant - Lexicon Pharmaceuticals
U.S. Army Medical Research & Development Command
U.S. Army Medical Research & Development Command investment in Grant - Lexicon Pharmaceuticals
Sofinov Societe Financiere D'Innovation
Sofinov Societe Financiere D'Innovation investment in Post-IPO Equity - Lexicon Pharmaceuticals
Punk, Ziegel & Company
Punk, Ziegel & Company investment in Post-IPO Equity - Lexicon Pharmaceuticals
Bay City Capital
Bay City Capital investment in Post-IPO Equity - Lexicon Pharmaceuticals
BCM Technologies (BCMT)
BCM Technologies (BCMT) investment in Post-IPO Equity - Lexicon Pharmaceuticals
Official Site Inspections
http://www.lexpharma.com Semrush global rank: 2.14 M Semrush visits lastest month: 9.37 K
- Host name: ec2-3-94-225-107.compute-1.amazonaws.com
- IP address: 3.94.225.107
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Lexicon Pharmaceuticals"
Lexicon Pharmaceuticals, Inc.
Nov 14, 2024 · We are a biopharmaceutical company with a mission of pioneering medicines that transform patients' lives. Watch Our Story. What's New? See All News. Therapeutic Areas. Through our unique approach to gene science based on Nobel Prize-winning technology, we …See details»
Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals is a biopharmaceutical company that is applying a unique approach to gene science based on Nobel Prize-winning technology to discover and develop precise medicines for people with serious, chronic …See details»
Lexicon Corporate Presentation September 2024 - lexpharma.com
STRATEGY. Driving value and growth for Lexicon with opportunities that have the most impact for patients. Lead to Succeed is designed to drive value and growth across portfolio. Refocusing resources where Lexicon has potential to lead and succeed. Prioritizing investment in …See details»
ООО "ЛексФАРМА"
Программа электронного документооборота фармацевтической системы качества «Оптимус-ФАРМА» Система позволяет пользователям интуитивно понятным способом реализовывать документооборот всех регламентирующих и регистрирующих …See details»
Lexicon Pharmaceuticals, Inc. | LinkedIn
Corporate Overview Lexicon Pharmaceuticals is a biopharmaceutical company that has harnessed the power of genetics for drug discovery. Our research team has generated a pipeline of novel drug...See details»
Lexicon Pharmaceuticals - Wikipedia
Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company developing treatments for human disease. The company was founded in 1995 in The Woodlands, Texas under the name Lexicon Genetics, Incorporated by co-founders Professor Allan Bradley, FRS and Professor Bradley's …See details»
About Us — ООО "ЛексФАРМА" - lexpharma.org
The LexPHARMA Ltd team comprises highly qualified multidisciplinary pharmaceutical specialists with a broad professional experience in manufacturing and marketing authorisation of medicinal products. They have a unique background in regulatory agencies and pharmaceutical …See details»
Lexicon Pharmaceuticals - Crunchbase Company Profile & Funding
Lexicon Pharmaceuticals is a biopharmaceutical company that discovers and develops precise medicines for human disease. The Woodlands, Texas, United States. 101-250. Post-IPO Equity. Public. www.lexpharma.com. 2,915. Stock Symbol NASDAQ:LXRX. Acquisitions 1. Total …See details»
Overview, News & Similar companies - ZoomInfo.com
Jul 7, 2024 · Lexicon Pharmaceuticals contact info: Phone number: (281) 863-3000 Website: www.lexpharma.com What does Lexicon Pharmaceuticals do? Lexicon Pharmaceuticals is a biopharmaceutical company that is applying a unique approach to gene science based on …See details»
Contact Us | Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals' mission is to pioneer medicines that transform patients' lives. As an element of this mission, we are committed to supporting organizations working to promote excellence in patient care and provide valuable information to the medical and patient …See details»
Lexicon Pharmaceuticals Provides Business and ... - Markets Insider
THE WOODLANDS, Texas, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company with a mission of pioneering medicines that transform patients’...See details»
Lexicon to Reposition as Clinical Development-Focused Company …
THE WOODLANDS, Texas, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that the company has made the strategic decision to eliminate its commercial...See details»
Lexicon Pharmaceuticals Provides Business and Pipeline Update at …
THE WOODLANDS, Texas, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company with a mission of pioneering medicines that transform patients’...See details»
Lexicon to Reposition as Clinical Development-Focused
6 days ago · Implementing Strategic Restructuring to Eliminate Commercial Organization and Rationalize Operations Across All Functions Prioritizing Strong R&D...See details»
Investors | Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals is a fully integrated biopharmaceutical company that is applying a unique approach to gene science based on Nobel Prize-winning technology to discover and develop precise medicines for patients with serious, chronic conditions.See details»
Lexicon to Reposition as Clinical Development-Focused Company …
6 days ago · About Lexicon Pharmaceuticals Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Through the Genome5000™ program, Lexicon’s unique ...See details»
Lexicon Pharmaceuticals to Present at the Oppenheimer Fall …
Sep 15, 2021 · Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Through its Genome5000™ program, Lexicon scientists studied the role and function...See details»
ANNUAL REPORT 2022 - Lexicon Pharmaceuticals
TAKING FLIGHT - OUR STORY Pioneering the future with a unique application of gene science, Lexicon discovers and develops innovative and precise medicines for people with serious, chronic conditions. 1. Advancing from the foundationalSee details»
Lexicon Pharmaceuticals Receives December 20, 2024 PDUFA Goal …
Jul 16, 2024 · LXRX. Lexicon Pharmaceuticals, Inc. Launch Preparations Actively Underway; Launch Planned for Early 2025. Lexicon Seeks Approval for Zynquista™ (sotagliflozin) as an Adjunct to Insulin...See details»
News | Lexicon Pharmaceuticals, Inc.
Media Inquiries: Corporate Communications [email protected]. Investor Inquiries: Investor Relations [email protected]. Explore Investor Relations See Investors PageSee details»